Henlius Gets Green Light For Adalimumab In China

Company Expands Biosimilars Portfolio With Its Third Monoclonal Antibody

 
• By Akriti Seth
  
China_thumbsup
Henlius gets its third biosimilar approved for the Chinese market • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin